Previous Page  14 / 23 Next Page
Information
Show Menu
Previous Page 14 / 23 Next Page
Page Background

Page 45

A n n u a l S u mm i t o n

Hepatology and Pancreatic

Diseases

November 12-13 , 2018

Par i s , France

Journal of Clinical Gastroenterology and Hepatology

ISSN: 2575-7733

Hepatology and Pancreatic Diseases 2018

A

s many as 200 million people worldwide are infected with hepatitis C virus (HCV) and more than 350,000 people die yearly

from hepatitis C-related diseases (WHO, June 2011). There is no preventive vaccine available for HCV due to its highly

mutable nature evidenced by the presence of more than 50 subtypes of HCV. In the present study, the water extract of the leaves

of the wild Egyptian artichoke (WEA) (

Cynara cardunculus

L. var. sylvestris (Lam.) Fiori) showed improvement of HCV infection

symptoms through the clinical investigation of WEA extract on some infected Egyptian patients. The results showed outstanding

activity against HCV and its complications such as ascites and jaundice by measuring the PCR, and liver functions such as ALT,

and AST

1

. The phytochemistry of the WEA extract and its subsequent evaluation of inhibition capacity

in vitro

using cell-culture

derived HCV resulted in the identification of two potent sesquiterpene lactones showing

in vitro

activity against all genotypes

2

.

Their structural elucidation was done by extensive spectroscopic tools such as NMR and HR-MS spectroscopy. The absolute

configuration was determined by TDDFT ECD calculations and comparison with the experimental CD spectra. Cynaropicrin and

grosheimol showed EC

50

at 1.03 μM, and 1.27 μM, by using a luciferase-carrying reporter virus. Time-of-addition experiments

revealed that these compounds inhibited HCV virus at a time-point during entry. Finally, the results showed that compounds

cynaropicrin and grosheimol inhibited HCV particles from genotypes 1a, 1b, 2b, 3a, 4a, 5a, 6a and 7a indicating that these

compounds inhibit HCV cell entry independently of viral genotype or subtype. Most important is that compound cynaropicrin can

inhibit HCV through many important mechanisms: cell-entry inhibitor, inhibition of cell to cell coinfection, antihyperlipedemic and

antitumor activities

3

. There is a plenty of publications confirmed that cynaropicrin is a very promising drug as antitumor agent3.

elsebai72@yahoo.com

Promising Natural Compounds for Treatment of

Hepatitis C Virus and its Complications

Mahmoud F. Elsebai

Mansoura University, Egypt

J Clin Gastroenterol Hepatol 2018, Volume:2

DOI: 10.21767/2575-7733-C3-009